Funding for Alberta startups

Accelerate Fund supports the growth of early-stage Alberta technology companies with a venture capital fund that matches angel investment. We are currently seeking qualified companies for the $23-million Accelerate Fund III. The original $10-million Accelerate Fund I and Fund II are fully invested in these forward-looking businesses.

Learn About The Fund


Patented ophthalmic laser system diagnoses and treats eye diseases.

Bringing on an investor is a long term relationship. In the early days of working with Accelerate, it became clear the team has the track record, credibility, and expertise to support their portfolio companies in reaching the next level.

Liz O’Connell CEO and Co-Founder, Arolytics

Finding the right investor is a critical step for a high-growth technology company. We chose Accelerate Fund because of their reputation, their strong network, and the chemistry we felt with the team.

Wesley Sessenwein CEO and Founder, PayShepherd

It was important to us to have strong relationships and alignment with local investors who believe in what we’re doing. Accelerate Fund led our pre-seed round and helped attract other angels wanting to invest in us.

Lana Cuthbertson CEO and Founder of Areto Labs

The Accelerate Fund team was an early believer in us, which helped bring other investors onboard. They are trusted advisors who understand the nuances of an early-stage high-growth business.

Clayton Feick CEO of Ontopical

Accelerate Fund has followed Ambyint’s journey for several years and their validation, as a new investor, is most welcome. We value their guidance and connections in the industry as we continue to scale our operations in Alberta.

Benjamin Kemp CEO of Ambyint

Are you a fast-growing Alberta tech startup looking for early-stage funding?


Meet the Alberta tech businesses we've funded.

View Portfolio

Our community

Latest news

Accelerate Fund III invests in CARE Group to expand digital mental health technologies and programs

Read More

Want an investor that cares about impact and returns? Look beyond the fund’s name.

Read More

Accelerate Fund III invests in PulseMedica to expand treatment options for millions of people with eye disease

Read More